Consensus-Based Definitions for Vocal Biomarkers: The International VOCAL Initiative.

Authors

Megane Pizzimenti, Ayush Kalia, Jamie A Toghranegar, Mohamed Ebraheem, Nicholas Cummins, Satrajit S Ghosh, James T Anibal, Rhoda Au, Arian Azarang, Ruth H Bahr, Steven D Bedrick, Hugo Botha, Oita C Coleman, Abir Elbeji, Lampros C Kourtis, Anais Rameau, Jaskanwal Deep Singh Sara, Stephanie Watts, Daria Hemmerling, Jiri Mekyska, Marisha L Speights, Bridge2AI Voice Consortium, eVoiceNet COST Action (CA24128), Jean-Christophe Belisle-Pipon, Yael E Bensoussan, Guy Fagherazzi

Published in

medRxiv : the preprint server for health sciences. Dec 03, 2025. Epub Dec 03, 2025.

Abstract

Voice-based health technologies are growing rapidly, but they lack standardized terminology, which hinders interdisciplinary collaboration, research quality, and clinical translation.
The objective of this work is to develop universally accepted definitions in the rapidly evolving field of vocal biomarkers, as part of the VOCAL (Vocal Biomarker Guidelines for Ontology, Classification, Application, and Logistics) initiative, a structured, international consensus-based framework that aims to provide standards, and guidelines.
VOCAL is a rigorous, international, multi-stage consensus-building study conducted in 2024-2025.
Multi-institutional collaboration between representatives from the Bridge2AI-Voice Consortium (North America) and the eVoiceNet Network (European Union), culminating in an in person workshop at the 2025 Bridge2AI Voice Symposium.
A group of 24 international experts in medicine, clinical research, speech and language, audio signal processing, statistics, methodology, regulation, ethics.
VOCAL's iterative process involved five rounds of review, feedback, and an in-person workshop at the international 2025 Bridge2AI Voice Symposium, ensuring the incorporation of diverse perspectives and achieving a robust agreement on the proposed definitions.
Consensus-based definitions for vocal biomarkers, spanning from broad concepts (biomarker, digital biomarker, vocal biomarker) to domain-specific measures (cardio-respiratory acoustic, voice, speech/articulatory, cognitive/language).
A hierarchical continuum model of vocal biomarkers was established. We first distinguished between the concepts of vocal measures and vocal biomarkers. We then defined terms from broad, overarching concepts (Level 0: Biomarker, Digital Biomarker, Vocal Biomarker) to more specific physiological and cognitive domains (Level 1: Cardio-Respiratory Acoustic; Level 2: Voice; Level 3: Speech/Articulatory; Level 4: Cognitive/Language, including linguistic and paralinguistic subtypes).
This work provides a shared vocabulary that is essential for fostering communication through interdisciplinary collaboration, improving the quality and efficiency of research and development, and ensuring the ethical, reliable, and scalable deployment of future voice-based health technologies. It lays foundational groundwork for upcoming guidelines and standards, which are crucial for advancing the field of vocal biomarkers into widespread clinical utility.

PMID:
41404273
Bibliographic data and abstract were imported from PubMed on 17 Dec 2025.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.